Czasopismo Clinical and Experimental Hepatology 2021

Overview of lenvatinib as a targeted therapy for advanced hepatocellular carcinoma

Obaid Rehman, Urooj Jaferi, Inderbir Padda, Nimrat Khehra, Harshan Atwal, Dina Mossabeh, Ranvir Bhangu

Clin Exp HEPATOL 2021; 7, 3: 249-257

DOI: https://doi.org/10.5114/ceh.2021.109312

Abstract View text

Direct antiviral agents for chronic hepatitis C virus infection improve health-related quality of life significantly in the long term

Mahmoud Atamla, Johad Khoury, Ihab Dabbah, Rimma Kramsky, Afif Yaacob, Ella Veitsman, Tarek Saadi

Clin Exp HEPATOL 2021; 7, 3: 258-263

DOI: https://doi.org/10.5114/ceh.2021.109192

Abstract View text

Effect of abdominal fat distribution on severity of acute pancreatitis

Engin Beydogan, Semih Gulle, Celal Gezer, Banu Boyuk

Clin Exp HEPATOL 2021; 7, 3: 264-269

DOI: https://doi.org/10.5114/ceh.2021.109345

Abstract View text

Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification

Maurizio Cesari, Anna Chiara Frigo, Salvatore Piano, Paolo Angeli

Clin Exp HEPATOL 2021; 7, 3: 270-277

DOI: https://doi.org/10.5114/ceh.2021.108708

Abstract View text

Evaluation of interleukin 8 polymorphisms (-251T/A and +781C/T) in patients with hepatocellular carcinoma: a meta-analysis

Omid Emami Aleagha, Forouzan Moeinzadeh, Seyedeh Farnaz Moeini Shokouh, Erkan Doğan, Masoud Sadeghi

Clin Exp HEPATOL 2021; 7, 3: 278-285

DOI: https://doi.org/10.5114/ceh.2021.109424

Abstract View text

Prevalence and predictors of post-liver transplantation metabolic bone diseases

Maha Elsabaawy, Sameh Afify, Gasser El-Azab, Asmaa Gomaa, Nabil Omar, Mohamed Hashim, Dalia Elsabaawy, Helmy Elshazly

Clin Exp HEPATOL 2021; 7, 3: 286-292

DOI: https://doi.org/10.5114/ceh.2021.109412

Abstract View text

Relation between levels of toll-like receptors 3 and 7 and clinical profile of Child-Pugh B cirrhotic patients

Ahmed Kamal, Ahmed Ramadan, Dalia Sherief, Asmaa Hassan, Nahla Nosair, Maaly Mabrouk, Eman Habeeb, Tamer Haydra

Clin Exp HEPATOL 2021; 7, 3: 293-296

DOI: https://doi.org/10.5114/ceh.2021.109336

Abstract View text

Liver function test abnormalities in COVID-19 patients and factors affecting them – a retrospective study

Mona Mohammed Abdelrahman, Asmaa A. Abdel-baset, Mustafa Adel Younis, Mahmoud Gaber Mahmoud, Noha Saber Shafik

Clin Exp HEPATOL 2021; 7, 3: 297-304

DOI: https://doi.org/10.5114/ceh.2021.109225

Abstract View text

Metabolic associated fatty liver disease and adverse maternal and fetal outcomes: a systematic review and meta-analysis

Adinda Ayu Dyah, Rahadina Rahadina

Clin Exp HEPATOL 2021; 7, 3: 305-311

DOI: https://doi.org/10.5114/ceh.2021.109228

Abstract View text

Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study

Tary Salman, Maha Elsabaawy, Mahmoud Omar, Mohamed Afify, Hossam Elezawy, Samar Ghanem, Osama Abdelraouf, Eman Rewisha, Nashwa Shebl

Clin Exp HEPATOL 2021; 7, 3: 312-319

DOI: https://doi.org/10.5114/ceh.2021.109292

Abstract View text

Hyaluronic acid as a potential marker for assessment of fibrosis regression after direct acting antiviral drugs in chronic hepatitis C patients

Eman Rewisha, Tary Salman, Omkolsoum Alhaddad, Gamal Abo Raia, Mary Naguib, Shymaa Rashad, Ahmed Abdelfattah, Khaled Metwally, Eman Abdelsameea

Clin Exp HEPATOL 2021; 7, 3: 320-327

DOI: https://doi.org/10.5114/ceh.2021.109293

Abstract View text

Overview of lenvatinib as a targeted therapy for advanced hepatocellular carcinoma

Direct antiviral agents for chronic hepatitis C virus infection improve health-related quality of life significantly in the long term

Effect of abdominal fat distribution on severity of acute pancreatitis

Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification

Evaluation of interleukin 8 polymorphisms (-251T/A and +781C/T) in patients with hepatocellular carcinoma: a meta-analysis

Prevalence and predictors of post-liver transplantation metabolic bone diseases

Relation between levels of toll-like receptors 3 and 7 and clinical profile of Child-Pugh B cirrhotic patients

Liver function test abnormalities in COVID-19 patients and factors affecting them – a retrospective study

Metabolic associated fatty liver disease and adverse maternal and fetal outcomes: a systematic review and meta-analysis

Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study

Hyaluronic acid as a potential marker for assessment of fibrosis regression after direct acting antiviral drugs in chronic hepatitis C patients

Coverage in

Integrated with

Editorial Policies